Late Domain-Dependent Inhibition of Equine Infectious Anemia Virus Budding
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
The Gag proteins of a number of different retroviruses contain late or L domains that promote the release of virions from the plasma membrane. Three types of L domains have been identified to date: Pro-Thr-Ala-Pro (PTAP), Pro-Pro-X-Tyr, and Tyr-Pro-Asp-Leu. It has previously been demonstrated that overexpression of the N-terminal, E2-like domain of the endosomal sorting factor TSG101 (TSG-5′) inhibits human immunodeficiency virus type 1 (HIV-1) release but does not affect the release of the PPPY-containing retrovirus murine leukemia virus (MLV), whereas overexpression of the C-terminal portion of TSG101 (TSG-3′) potently disrupts both HIV-1 and MLV budding. In addition, it has been reported that, while the release of a number of retroviruses is disrupted by proteasome inhibitors, equine infectious anemia virus (EIAV) budding is not affected by these agents. In this study, we tested the ability of TSG-5′, TSG-3′, and full-length TSG101 (TSG-F) overexpression, a dominant negative form of the AAA ATPase Vps4, and proteasome inhibitors to disrupt the budding of EIAV particles bearing each of the three types of L domain. The results indicate that (i) inhibition by TSG-5′ correlates with dependence on PTAP; (ii) the release of wild-type EIAV (EIAV/WT) is insensitive to TSG-3′, whereas this C-terminal TSG101 fragment potently impairs the budding of EIAV when it is rendered PTAP or PPPY dependent; (iii) budding of all EIAV clones is blocked by dominant negative Vps4; and (iv) EIAV/WT release is not impaired by proteasome inhibitors, while EIAV/PTAP and EIAV/PPPY release is strongly disrupted by these compounds. These findings highlight intriguing similarities and differences in host factor utilization by retroviral L domains and suggest that the insensitivity of EIAV to proteasome inhibitors is conferred by the L domain itself and not by determinants in Gag outside the L domain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding
Garrus, J. E., von Schwedler, U. K., Pornillos, O. W., Morham, S. G., Zavitz, K. H., Wang, H. E., Wettstein, D. A., Stray, K. M., Côté, M., Rich, R. L., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00506-2 · Cited by 1,369 · cited 5×
“As previously reported (17), Vps4EQ strongly inhibited HIV-1 release.”
BackgroundInfluentialReceptor downregulation and multivesicular-body sorting
Katzmann, D. J., Odorizzi, G., & Emr, S. D. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm973 · Cited by 1,201 · cited 9×
“A key aspect of the endosomal sorting pathway is the delivery of cargo proteins to vesicles that bud into late endosomes to form multivesicular bodies (MVBs).”
BackgroundInfluentialAIP1/ALIX Is a Binding Partner for HIV-1 p6 and EIAV p9 Functioning in Virus Budding
Strack, B., Calistri, A., Craig, S., Popova, E., & Göttlinger, H. G. (2003) · Cell · doi:10.1016/s0092-8674(03)00653-6 · Cited by 825
HIV-1 Gag proteins: diverse functions in the virus life cycle
Freed, E. O. (1998) · Virology · doi:10.1006/viro.1998.9398 · Cited by 717 · cited 1×
“During or shortly after release from the cell, the Gag precursor is proteolytically cleaved by the viral protease to generate the mature Gag proteins, which generally include matrix (MA), capsid, and nucleocapsid, and a variety of spacer peptides and domains unique to individual retrovirus genera (14, 70).”
BackgroundSelf-citationMartin-Serrano, J., Zang, T., & Bieniasz, P. D. (2001) · Nature Medicine · doi:10.1038/nm1201-1313 · Cited by 710 · cited 3×
“and Ebola virus (38, 41, 72) and functions in the release of * Corresponding author.”
BackgroundFab1p PtdIns(3)P 5-Kinase Function Essential for Protein Sorting in the Multivesicular Body
Odorizzi, G., Babst, M., & Emr, S. D. (1998) · Cell · doi:10.1016/s0092-8674(00)81707-9 · Cited by 656 · cited 1×
“The contents of these vesicles are ultimately delivered to the lysosome or vacuole, where they are degraded or serve a proteolytic function (40, 45).”
BackgroundEffect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release
Göttlinger, H. G., Dorfman, T., Sodroski, J. G., & Haseltine, W. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.8.3195 · Cited by 647 · cited 1×
“It is well established that a PTAP motif near the N terminus of p6 acts as the L domain of human immunodeficiency virus type 1 (HIV-1) (19, 26).”
BackgroundTsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55 Gag
VerPlank, L., Bouamr, F., LaGrassa, T. J., Agresta, B., Kikonyogo, A., Leis, J., & Carter, C. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.131059198 · Cited by 584 · cited 2×
“(iii) TSG101 can bind p6 in the absence of the Gag-Ub modification, though ubiquitination may enhance binding (17, 57, 74).”
BackgroundForm, function, and use of retroviral Gag proteins
Wills, J. W., & Craven, R. C. (1991) · AIDS · doi:10.1097/00002030-199106000-00002 · Cited by 515
Huang, M., Orenstein, J. M., Martin, M. A., & Freed, E. O. (1995) · Journal of Virology · doi:10.1128/jvi.69.11.6810-6818.1995 · Cited by 486
Self-citation
Cited by
Mechanisms for enveloped virus budding: Can some viruses do without an ESCRT?
Chen, B. J., & Lamb, R. A. (2008) · Virology · doi:10.1016/j.virol.2007.11.008 · Cited by 283
Demirov, D. G., & Freed, E. O. (2004) · Virus Research · doi:10.1016/j.virusres.2004.08.007 · Cited by 275
Self-citationHuman immunodeficiency virus type 1 assembly, release, and maturation
Adamson, C. S., & Freed, E. O. (2007) · Advances in Pharmacology · doi:10.1016/s1054-3589(07)55010-6 · Cited by 179
Self-citationHuman ESCRT-II Complex and Its Role in Human Immunodeficiency Virus Type 1 Release
Langelier, C., von Schwedler, U. K., Fisher, R. D., De Domenico, I., White, P. L., Hill, C. P., Kaplan, J., Ward, D., & Sundquist, W. I. (2006) · Journal of Virology · doi:10.1128/jvi.01049-06 · Cited by 166
“HIV-1, which binds directly to TSG101, requires all of the known ESCRT-I components for efficient release (19, 22, 48), whereas equine infectious anemia virus and Moloney murine leukemia virus, which bud primarily via ALIX and the Nedd4 E3 ligases, respectively, exhibit little or no requirement for TSG101/ESCRT-I (22,…”
BackgroundInfluentialDussupt, V., Javid, M. P., Abou-Jaoudé, G., Jadwin, J. A., de La Cruz, J., Nagashima, K., & Bouamr, F. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000339 · Cited by 148
“When transplanted into the retroviral Gag of RSV [58], MLV [59]or EIAV [77], the PTAP sequence of HIV-1 p6 retains some level of release-driving activity.”
BackgroundInfluential
Metadata
- Authors
- Shehu-Xhilaga, M., Ablan, S., Demirov, D. G., Chen, C., Montelaro, R. C., & Freed, E. O.
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2004-01-15
- Volume
- 78
- Issue
- 2
- Pages
- 724-732
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- OpenAlex
- W2148146181
- Cited by
- 64
- References
- 20
- FWCI
- 2.60
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.